Dr. Dennis Slamon, Chief of UCLAs Division of Hematology/Oncology presents a review of the progress achieved in the treatment of various cancers by the molecular analysis of the tumors, prior to treatment. Series: Jonsson Cancer Center at UCLA [9/2009] [Health and Medicine] [Professional Medical Education] [Show ID: 16932]
"Cancer" is too vague. Subtypes should be the "types."
You have "HER2 Positive"....
WoundedEgo 2 years ago
they say not to have suger when you have cancer but aspertane is worse!!!
singlaprety12 2 years ago
very interesting thank you for the upload.
ueks69 2 years ago
Thank you for this, a very interesting lecture.
chris3443 2 years ago